Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.
Publication
, Journal Article
Kramer, JM
Published in: N Engl J Med
April 16, 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
April 16, 2009
Volume
360
Issue
16
Start / End Page
1592 / 1595
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Risk Assessment
- Humans
- General & Internal Medicine
- Drug Labeling
- Drug Approval
- Delayed-Action Preparations
- Bronchodilator Agents
- Asthma
Citation
APA
Chicago
ICMJE
MLA
NLM
Kramer, J. M. (2009). Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values. N Engl J Med, 360(16), 1592–1595. https://doi.org/10.1056/NEJMp0810561
Kramer, Judith M. “Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.” N Engl J Med 360, no. 16 (April 16, 2009): 1592–95. https://doi.org/10.1056/NEJMp0810561.
Kramer JM. Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values. N Engl J Med. 2009 Apr 16;360(16):1592–5.
Kramer, Judith M. “Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.” N Engl J Med, vol. 360, no. 16, Apr. 2009, pp. 1592–95. Pubmed, doi:10.1056/NEJMp0810561.
Kramer JM. Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values. N Engl J Med. 2009 Apr 16;360(16):1592–1595.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
April 16, 2009
Volume
360
Issue
16
Start / End Page
1592 / 1595
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Risk Assessment
- Humans
- General & Internal Medicine
- Drug Labeling
- Drug Approval
- Delayed-Action Preparations
- Bronchodilator Agents
- Asthma